Skip to main content
. 2022 Aug 11;22:541. doi: 10.1186/s12888-022-04184-8

Table 1.

Demographic and clinical characteristics of the incident study cohort (patients with the start of any major depressive disorder episode within the study period, 1/1/2016–31/5/2018) at treatment initiation, n = 2553

Patient characteristics Patients without TRD (N = 1929, 75.6%) Patients with TRD (N = 624, 24.4%) Total (N = 2553) P-value
Age, y Median (IQR) 46 (35, 55) 49 (38, 56) 47 (36, 56) 0.001
Sex Male 672 (34.8%) 237 (38.0%) 909 (35.6%) 0.154
Female 1257 (65.2%) 387 (62.0%) 1644 (64.4%)
Socio-economic status Low 581 (30.1%) 188 (30.1%) 769 (30.1%) 0.711
Medium 402 (20.8%) 121 (19.4%) 523 (20.5%)
High 946 (49.0%) 315 (50.5%) 1261 (49.4%)
District Central 1348 (69.9%) 472 (75.6%) 1820 (71.3%) 0.021
North 403 (20.9%) 104 (16.7%) 507 (19.9%)
South 178 (9.2%) 48 (7.7%) 226 (8.9%)
Comorbidities Deyo-Charlson co-morbidity index, mean (SD) 0.88 (1.55) 0.90 (1.47) 0.89 (1.53) 0.788
Diabetes mellitus 207 (10.7%) 76 (12.2%) 283 (11.1%) 0.316
Cardio-vascular disease 157 (8.1%) 65 (10.4%) 222 (8.7%) 0.079
Hypertension 395 (20.5%) 157 (25.2%) 552 (21.6%) 0.014
Chronic obstructive pulmonary disease 50 (2.6%) 21 (3.4%) 71 (2.8%) 0.307
Cancer 141 (7.3%) 46 (7.4%) 187 (7.3%) 0.959
Osteoporosis 108 (5.6%) 43 (6.9%) 151 (5.9%) 0.234
Other co-morbidities * Post-partum depression 5 (0.3%) 0 (0.0%) 5 (0.2%) 0.203
Anxiety 460 (23.8%) 162 (26.0%) 622 (24.4%) 0.285
Panic attacks 72 (3.7%) 16 (2.6%) 88 (3.4%) 0.241
Personality disorder 103 (5.3%) 52 (8.3%) 155 (6.1%) 0.006
Social phobia 16 (0.8%) 7 (1.1%) 23 (0.9%) 0.502
Smoking Ever 926 (48.2%) 319 (51.1%) 1245 (48.9%) 0.324
Never 995 (51.7%) 305 (48.9%) 1300 (51.0%)
Missing 2 (0.1%) 0 (0.0%) 2 (0.1%)
Body mass index ** Mean (SD) 26.54 (5.6) 26.66 (5.59) 26.57 (5.6) 0.635

* within 1 year prior to index date

** for those with a BMI measurement closest within 5 years before index date, n = 2374 (93.3%)

TRD treatment resistant depression